In fact when diabetic PAD patients were divided into two clinical categories, consisting in patients affected by stable PAD and in patients affected by CLI, HMGB-1 serum levels were significantly higher in patients affected by CLI than stable PAD (P < 0.001). The gene discussed is HMGB1; the disease is peripheral arterial disease.